AstraZeneca PLC American Depositary Shares (AZN)
NASDAQ
Closed
Oct 9, 2026
Day's Range
158.5352 wk Range
153.41Overview - AZN - AstraZeneca PLC American Depositary Shares
Key Statistics
Valuation
Enterprise Value
270.80B
P/E (Trailing)
‪23.59‬
P/E (Forward)
‪13.54‬
PEG Ratio
‪12.42‬
Price / Sales (TTM)
‪3.96‬
Price / Book
‪4.83‬
EV / EBITDA
‪13.60‬
Profitability
Gross Margin
‪83.59%‬
Profit Margin
‪17.02%‬
Operating Margin
‪23.45%‬
Return on Assets
‪8.01%‬
Return on Equity
‪21.96%‬
Ownership
Shares Outstanding
1.55B
Float
1.54B
Short % of Shares Outstanding
‪0.13%‬
Held by Insiders
‪0.05%‬
Held by Institutions
‪65.01%‬
Price stats
Beta
‪0.20‬
50-Day Avg
‪163.34‬
200-Day Avg
‪182.11‬
Dividends
Payout Ratio
‪47.41%‬
Frequency
Semi-Annual
Analyst Consensus
11 analysts
Average price target
‪$ 213.99‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AZN - AstraZeneca PLC American Depositary Shares
Peers - AZN - AstraZeneca PLC American Depositary Shares
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NASDAQ.
- AZNNASDAQAstraZeneca PLC243.33BMarket Cap-8.97%52-week change23.59P/E (Trailing)‪17.02%‬Profit Margin
- AMGNNASDAQAmgen Inc.217.89BMarket Cap+27.02%52-week change25.05P/E (Trailing)‪22.95%‬Profit Margin
- GILDNASDAQGilead Sciences, Inc.179.47BMarket Cap+21.53%52-week change17.87P/E (Trailing)‪-10.63%‬Profit Margin
- SNYNASDAQSanofi ADR95.65BMarket Cap-24.52%52-week change21.01P/E (Trailing)‪8.09%‬Profit Margin
- ROPNASDAQRoper Technologies Inc.35.05BMarket Cap-41.10%52-week change14.55P/E (Trailing)‪30.24%‬Profit Margin
- BIIBNASDAQBiogen Inc.32.48BMarket Cap+29.94%52-week change39.06P/E (Trailing)‪8.32%‬Profit Margin
- GRFSNASDAQGrifols S.A. ADR4.97BMarket Cap-31.46%52-week change9.75P/E (Trailing)‪6.09%‬Profit Margin
Profile Summary - AZN - AstraZeneca PLC American Depositary Shares
About
AstraZeneca PLC American Depositary Shares represent ownership in AstraZeneca PLC, a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. AstraZeneca’s current business spans Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
